Aixia Ma

462 total citations
19 papers, 298 citations indexed

About

Aixia Ma is a scholar working on Economics and Econometrics, General Health Professions and Surgery. According to data from OpenAlex, Aixia Ma has authored 19 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 4 papers in General Health Professions and 3 papers in Surgery. Recurrent topics in Aixia Ma's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Economic and Financial Impacts of Cancer (4 papers) and Pharmaceutical Economics and Policy (4 papers). Aixia Ma is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Economic and Financial Impacts of Cancer (4 papers) and Pharmaceutical Economics and Policy (4 papers). Aixia Ma collaborates with scholars based in China, United States and Hong Kong. Aixia Ma's co-authors include Ting Zhou, Haijing Guan, Yao Zhang, Mingjun Rui, Xiaomo Xiong, Thomas T. H. Wan, Binshan Lin, Haitao Li, Xiaolin Wei and Roger Yat‐Nork Chung and has published in prestigious journals such as Medicine, Quality of Life Research and Frontiers in Pharmacology.

In The Last Decade

Aixia Ma

16 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aixia Ma China 8 115 99 37 32 29 19 298
Elizabeth Brouwer United States 10 90 0.8× 92 0.9× 27 0.7× 33 1.0× 28 1.0× 17 355
Aureliano Paolo Finch Netherlands 12 250 2.2× 109 1.1× 30 0.8× 26 0.8× 9 0.3× 26 421
Sirinart Tongsiri Thailand 6 127 1.1× 88 0.9× 35 0.9× 11 0.3× 11 0.4× 13 284
Lisa Van Wilder Belgium 11 109 0.9× 100 1.0× 75 2.0× 9 0.3× 28 1.0× 26 341
Néboa Zozaya Spain 10 106 0.9× 96 1.0× 36 1.0× 7 0.2× 20 0.7× 45 372
Christelle Gastaldi‐Ménager France 10 70 0.6× 72 0.7× 76 2.1× 15 0.5× 57 2.0× 23 314
Borja García‐Lorenzo Spain 9 237 2.1× 159 1.6× 50 1.4× 7 0.2× 25 0.9× 16 465
Freddie Henriksson Sweden 8 229 2.0× 68 0.7× 74 2.0× 15 0.5× 23 0.8× 15 528
Bisundev Mahato United States 6 110 1.0× 120 1.2× 22 0.6× 13 0.4× 21 0.7× 11 280
Suhui Li United States 11 112 1.0× 129 1.3× 18 0.5× 10 0.3× 28 1.0× 23 338

Countries citing papers authored by Aixia Ma

Since Specialization
Citations

This map shows the geographic impact of Aixia Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aixia Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aixia Ma more than expected).

Fields of papers citing papers by Aixia Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aixia Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aixia Ma. The network helps show where Aixia Ma may publish in the future.

Co-authorship network of co-authors of Aixia Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Aixia Ma. A scholar is included among the top collaborators of Aixia Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aixia Ma. Aixia Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wang, Lei, et al.. (2025). The effect of pharmacist intervention on medication adherence measured with proportion of days covered: a systematic review and meta-analysis. International Journal of Clinical Pharmacy. 47(6). 1590–1608. 1 indexed citations
4.
6.
Li, Yan, et al.. (2023). Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review. Applied Health Economics and Health Policy. 22(1). 33–48. 2 indexed citations
7.
Liu, Wei, et al.. (2023). A systematic review and meta-analysis of health utility values among patients with ischemic stroke. Frontiers in Neurology. 14. 1219679–1219679. 5 indexed citations
8.
Zhang, Mengran, Yan Zhang, Xi Su, et al.. (2021). Predictors of Quality of Life in Patients With Myocardial Infarction Combined With Dyslipidemia. Frontiers in Public Health. 9. 713480–713480. 7 indexed citations
9.
Zhou, Ting, et al.. (2021). Health-Related Quality of Life in Patients With Different Diseases Measured With the EQ-5D-5L: A Systematic Review. Frontiers in Public Health. 9. 675523–675523. 121 indexed citations
10.
Guan, Xin‐Yuan, Hongchao Li, Xiaomo Xiong, et al.. (2021). Cost-effectiveness analysis of fruquintinib versus regorafenib as the third-line therapy for metastatic colorectal cancer in China. Journal of Medical Economics. 24(1). 339–344. 14 indexed citations
12.
Xiong, Xiaomo, et al.. (2020). Cost-Effectiveness of Tofacitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis in China. PharmacoEconomics. 38(12). 1345–1358. 13 indexed citations
13.
Ma, Aixia, et al.. (2020). PCN117 COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB USED IN CHINESE PATIENTS WITH METASTATIC COLORECTAL CANCER. Value in Health. 23. S43–S43. 1 indexed citations
14.
Zhou, Ting, et al.. (2018). The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Quality of Life Research. 27(11). 2799–2814. 58 indexed citations
15.
Tang, Wenxi, et al.. (2017). Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing. Journal of Medical Economics. 21(4). 326–339. 21 indexed citations
16.
Li, Haitao, Xiaolin Wei, Aixia Ma, & Roger Yat‐Nork Chung. (2014). Inequalities in health status among rural residents: EQ-5D findings from household survey China. International Journal for Equity in Health. 13(1). 41–41. 20 indexed citations
17.
Liu, Yong‐Jun, Yajiong Xue, Gordon Liu, & Aixia Ma. (2013). Development of foreign invested hospitals in China: obstacles and coping strategies. Journal of Hospital Administration. 2(3). 142–142. 2 indexed citations
18.
Li, Haitao, Aixia Ma, Hongchao Li, & Shixue Li. (2009). Pharmacoeconomics in Healthcare Decision Making in China. Pharmaceutical Medicine. 23(5-6). 279–282. 2 indexed citations
19.
Wan, Thomas T. H., Aixia Ma, & Binshan Lin. (2001). Integration and the performance of healthcare networks: do integration strategies enhance efficiency, profitability, and image?. International Journal of Integrated Care. 1(2). e39–e39. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026